Concepedia

Marcel A. Deken

MA

Statistics

Publications

6

Citations

314

H-Index

6

Active since

2009

Affiliations

Oncode Institute(Current)

The Netherlands Cancer Institute

Amsterdam UMC Location Vrije Universiteit Amsterdam

Marcel A. Deken is an author at Oncode Institute specializing in oncology, medicine, and pharmacology.

Publications per year

2009–2023

6

Publications

6

Targeting the MAPK and PI3K pathways in combination with PD1 blockade in melanoma

Marcel A. Deken, Jules Gadiot, Ekaterina S. Jordanova et al. · OncoImmunology · 2016 · 146 citations · Full text

, , +17

Variation of Neisseria gonorrhoeae Lipooligosaccharide Directs Dendritic Cell–Induced T Helper Responses

Sandra J. van Vliet, Liana Steeghs, Sven C. M. Bruijns et al. · PLoS Pathogens · 2009 · 88 citations · Full text

, , +17

Concomitant targeting of programmed death-1 (PD-1) and CD137 improves the efficacy of radiotherapy in a mouse model of human BRAFV600-mutant melanoma

Paula Kroon, Jules Gadiot, Marlies J. W. Peeters et al. · Cancer Immunology Immunotherapy · 2016 · 34 citations · Full text

, , +17

Characterization and translational development of IOA-289, a novel autotaxin inhibitor for the treatment of solid tumors

Marcel A. Deken, Karolina Niewola‐Staszkowska, Olivier Peyruchaud et al. · Immuno-Oncology Technology · 2023 · 23 citations · Full text

, , +11

Synchronous BRAFV600E and MEK inhibition leads to superior control of murine melanoma by limiting MEK inhibitor induced skin toxicity

Christian Blank, Jules Gadiot, Anna I. Hooijkaas et al. · OncoTargets and Therapy · 2013 · 13 citations · Full text

, , +15

1–5 of 6